Isath A, et al. Trends, Prevalence, and outcomes of Sudden Cardiac arrest Post Cardiac Transplant: a nationwide 16-Year study. Current Problems in Cardiology; 2022;47(8).
Vakil K, et al. Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation. Heart Rhythm. 2014;11(10):1684–90.
Thajudeen A, et al. Arrhythmias after heart transplantation: mechanisms and management. J Am Heart Assoc. 2012;1(2):e001461.
Article PubMed PubMed Central Google Scholar
Hamon D, et al. Arrhythmias in the heart transplant patient. Arrhythm Electrophysiol Rev. 2014;3(3):149–55.
Article PubMed PubMed Central Google Scholar
Miyamoto Y, et al. Bradyarrhythmia after heart transplantation. Incidence, time course, and outcome. Circulation. 1990;82(5 Suppl):Iv313–7.
DiBiase A, et al. Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol. 1991;67(16):1385–9.
Article CAS PubMed Google Scholar
Jacquet L, et al. Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities. J Am Coll Cardiol. 1990;16(4):832–7.
Article CAS PubMed Google Scholar
Stecker EC, et al. Arrhythmias after orthotopic heart transplantation. J Card Fail. 2005;11(6):464–72.
Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Article PubMed PubMed Central Google Scholar
Shumway NE, Lower RR, Stofer RC. Transplantation of the heart. Adv Surg. 1966;2:265–84.
Colvin MM, et al. Antibody-mediated rejection in Cardiac Transplantation: emerging knowledge in diagnosis and management. Circulation. 2015;131(18):1608–39.
Costanzo MR, et al. The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transpl. 2010;29(8):914–56.
Jones DG, et al. Permanent pacemaker implantation early and late after heart transplantation: clinical indication, risk factors and prognostic implications. J Heart Lung Transpl. 2011;30(11):1257–65.
Ustunkaya T, et al. Clinical and procedural characteristics predicting need for chronotropic support and permanent pacing post-heart transplantation. Heart Rhythm. 2020;17(7):1132–8.
Doulamis IP et al. Pacemaker implantation following heart transplantation: analysis of a nation-wide database. J Clin Med, 2023. 12(4).
Mahmood A, et al. Permanent pacemaker implantation after pediatric heart transplantation: risk factors, indications, and outcomes. Clin Transpl. 2019;33(4):e13503.
DeFilippis EM, et al. Long-term outcomes of Permanent Pacemaker Implantation in Bicaval Heart Transplant recipients. JACC Clin Electrophysiol. 2023;9(9):1964–71.
Article PubMed PubMed Central Google Scholar
Mallidi HR, Bates M. Pacemaker use following heart transplantation. Ochsner J. 2017;17(1):20–4.
PubMed PubMed Central Google Scholar
Rivinius R, et al. Risk factors and survival of patients with permanent pacemaker implantation after heart transplantation. J Thorac Dis. 2019;11(12):5440–52.
Article PubMed PubMed Central Google Scholar
Zieroth S, et al. Permanent pacing after cardiac transplantation in the era of extended donors. J Heart Lung Transpl. 2006;25(9):1142–7.
Do DH, et al. Outcomes in orthotopic heart transplantation following pacemaker implantation. PACE - Pacing Clin Electrophysiol. 2023;46(7):583–91.
Yacoub MH, Banner NR. 1 - recent developments in lung and heart-lung transplantation. Transplantation Reviews. 1989;3:1–29.
Rothman SA, et al. Eliminating bradyarrhythmias after orthotopic heart transplantation. Circulation. 1996;94(9 Suppl):Ii278–82.
Holt ND, et al. Electrophysiological properties of the recipient atrial remnant after human orthotopic cardiac transplantation. Europace. 1999;1(3):187–91.
Article CAS PubMed Google Scholar
Bernhardt AM, et al. The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory support. J Card Fail. 2023;29(3):304–74.
Akca F, et al. Effects of increasing Donor Age on the risk of Permanent Pacing after Orthotopic Heart Transplantation. J Heart Lung Transplantation. 2016;35(4):S294.
Bertolet BD, et al. Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol. 1996;28(2):396–9.
Article CAS PubMed Google Scholar
Redmond JM, et al. Use of theophylline for treatment of prolonged sinus node dysfunction in human orthotopic heart transplantation. J Heart Lung Transpl. 1993;12(1 Pt 1):133–8. discussion 138-9.
Kooij C, et al. Theophylline Use to Prevent Permanent Pacing in the contemporary era of Heart Transplantation: the Rotterdam experience. Front Cardiovasc Med. 2022;9:896141.
Article PubMed PubMed Central Google Scholar
Wellmann P, et al. A single Center Study of 1,179 heart transplant patients—factors affecting pacemaker implantation. PACE - Pacing Clin Electrophysiol. 2017;40(3):247–54.
Cantillon DJ, et al. Long-term outcomes and clinical predictors for Pacing after Cardiac Transplantation. J Heart Lung Transplant. 2009;28(8):791–8.
Heinz G et al. Benign prognosis of early sinus node dysfunction after orthotopic cardiac transplantation. (0147–8389 (Print)).
Selmer OJF, Selmer RO, Fau - R, Strøm, Strøm O. Prognosis in cardiac pacing. A comparison between patients with atrioventricular block and sick sinus syndrome. (0001–6101 (Print)).
Qin D, et al. Short- and long-term risk of lead dislodgement events: real-world experience from product Surveillance Registry. Circulation: Arrhythmia and Electrophysiology; 2022;15(8):e011029.
Cinca J, et al. Changes in myocardial electrical impedance in human heart graft rejection. Eur J Heart Fail. 2008;10(6):594–600.
Lang CC, et al. Endocardial impedance mapping during circumferential pulmonary vein ablation of atrial fibrillation differentiates between atrial and venous tissue. Heart Rhythm. 2006;3(2):171–8.
Gregoratos G, et al. ACC/AHA guidelines for implantation of Cardiac pacemakers and Antiarrhythmia devices: executive Summary. Circulation. 1998;97(13):1325–35.
留言 (0)